193 related articles for article (PubMed ID: 21901222)
21. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells.
Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y
J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927
[TBL] [Abstract][Full Text] [Related]
22. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
23. pH-disintegrable polyelectrolyte multilayer-coated mesoporous silica nanoparticles exhibiting triggered co-release of cisplatin and model drug molecules.
Wan X; Zhang G; Liu S
Macromol Rapid Commun; 2011 Jul; 32(14):1082-9. PubMed ID: 21618323
[TBL] [Abstract][Full Text] [Related]
24. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
[TBL] [Abstract][Full Text] [Related]
25. Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties.
Chen S; Zhang H; Shi X; Wu H; Hanagata N
Lab Chip; 2014 Jun; 14(11):1842-9. PubMed ID: 24733088
[TBL] [Abstract][Full Text] [Related]
26. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
Zhu S; Zhou Z; Zhang D
Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
[TBL] [Abstract][Full Text] [Related]
27. Smart drug delivery through DNA/magnetic nanoparticle gates.
Ruiz-Hernández E; Baeza A; Vallet-Regí M
ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653
[TBL] [Abstract][Full Text] [Related]
28. Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles.
Aznar E; Mondragón L; Ros-Lis JV; Sancenón F; Marcos MD; Martínez-Máñez R; Soto J; Pérez-Payá E; Amorós P
Angew Chem Int Ed Engl; 2011 Nov; 50(47):11172-5. PubMed ID: 21953879
[No Abstract] [Full Text] [Related]
29. Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films.
Zhang Z; Cao X; Zhao X; Holt CM; Lewis AL; Lu JR
J Control Release; 2008 Aug; 130(1):69-76. PubMed ID: 18562037
[TBL] [Abstract][Full Text] [Related]
30. Aerosol fabrication of hollow mesoporous silica nanoparticles and encapsulation of L-methionine as a candidate drug cargo.
Jiang X; Ward TL; Cheng YS; Liu J; Brinker CJ
Chem Commun (Camb); 2010 May; 46(17):3019-21. PubMed ID: 20386854
[TBL] [Abstract][Full Text] [Related]
31. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Chen C; Geng J; Pu F; Yang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2011 Jan; 50(4):882-6. PubMed ID: 21246683
[No Abstract] [Full Text] [Related]
32. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
33. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
34. Study of UV-shielding properties of novel porous hollow silica nanoparticle carriers for avermectin.
Li ZZ; Chen JF; Liu F; Liu AQ; Wang Q; Sun HY; Wen LX
Pest Manag Sci; 2007 Mar; 63(3):241-6. PubMed ID: 17177171
[TBL] [Abstract][Full Text] [Related]
35. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.
Mortera R; Vivero-Escoto J; Slowing II; Garrone E; Onida B; Lin VS
Chem Commun (Camb); 2009 Jun; (22):3219-21. PubMed ID: 19587919
[TBL] [Abstract][Full Text] [Related]
36. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials.
Balas F; Manzano M; Horcajada P; Vallet-Regí M
J Am Chem Soc; 2006 Jun; 128(25):8116-7. PubMed ID: 16787058
[TBL] [Abstract][Full Text] [Related]
37. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
39. Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant.
Liu T; Liu H; Fu C; Li L; Chen D; Zhang Y; Tang F
J Colloid Interface Sci; 2013 Jun; 400():168-74. PubMed ID: 23582904
[TBL] [Abstract][Full Text] [Related]
40. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery.
Popat A; Jambhrunkar S; Zhang J; Yang J; Zhang H; Meka A; Yu C
Chem Commun (Camb); 2014 May; 50(42):5547-50. PubMed ID: 24603852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
